AN2690
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AN2690, covering 2018-02-20 to 2018-02-20. Get the full timeline:
Most recent: Clinical Trial Update: Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME II) [Phase 2]